Cargando…

Impact of therapeutic plasma exchange on acquired vaccinal anti-SARS-CoV-2 antibodies

Detalles Bibliográficos
Autores principales:	Lambert, Catherine, Scohy, Anais, Yombi, Jean Cyr, Goffin, Eric, Devresse, Arnaud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Federation of Internal Medicine. Published by Elsevier B.V. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841167/ https://www.ncbi.nlm.nih.gov/pubmed/35181184 http://dx.doi.org/10.1016/j.ejim.2022.02.014

Ejemplares similares

Better late than never: eventual seroconversion against SARS-CoV-2 in a kidney transplant recipient after repeated immune challenge and monoclonal antibody therapy
por: De Greef, Julien, et al.
Publicado: (2021)

Monoclonal Antibody Therapy in Kidney Transplant Recipients With Delta and Omicron Variants of SARS-CoV-2: A Single-Center Case Series
por: Fernandes, Guillaume, et al.
Publicado: (2022)

Immunosuppression and SARS-CoV-2 Infection in Kidney Transplant Recipients
por: Devresse, Arnaud, et al.
Publicado: (2022)

Evaluation of a commercial interferon-γ release assay for the detection of SARS-CoV-2 T-cell response after vaccination
por: Saad Albichr, Imane, et al.
Publicado: (2023)

In Reply to ‘Kidney Transplant Recipients With COVID-19 and Monoclonal Antibody Therapy: Additional Considerations’
por: Fernandes, Guillaume, et al.
Publicado: (2022)

Attenuated anti-SARS-CoV-2 antibody response to vaccination in patients with rheumatic diseases
por: Manolache, Narcis-George, et al.
Publicado: (2022)

High response rate to BNT162b2 mRNA COVID-19 vaccine among self-care dialysis patients
por: Georgery, Hélène, et al.
Publicado: (2021)

Safety, Efficacy, and Relapse of Nirmatrelvir-Ritonavir in Kidney Transplant Recipients Infected With SARS-CoV-2
por: Devresse, Arnaud, et al.
Publicado: (2022)

COVID-19 Infection in Kidney Transplant Recipients: A Single-Center Case Series of 22 Cases From Belgium
por: Devresse, Arnaud, et al.
Publicado: (2020)

Development of SARS-CoV2 humoral response including neutralizing antibodies is not sufficient to protect patients against fatal infection
por: Choteau, Mathilde, et al.
Publicado: (2022)

Safety and efficiency of molnupiravir for COVID-19 patients with advanced chronic kidney disease
por: Dufour, Inès, et al.
Publicado: (2023)

Lessons for the clinical nephrologist: lumasiran as the future cornerstone treatment for patients with primary hyperoxaluria type 1?
por: Gillion, Valentine, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 infection in health care workers of a teaching hospital in Belgium: self-reported occupational and household risk factors for seropositivity
por: Scohy, Anaïs, et al.
Publicado: (2021)

Nirmatrelvir-ritonavir chez les patients greffés rénaux infectés par le SARS-CoV-2 : l’expérience d’une cohorte belge
por: Devresse, A., et al.
Publicado: (2022)

A comparative analysis of the outcomes of patients with influenza or COVID-19 in a tertiary hospital in Belgium
por: Wallemacq, Silvio, et al.
Publicado: (2022)

Immunogenicity of BNT162b2 SARS-CoV-2 Vaccine in a Multicenter Cohort of Nursing Home Residents Receiving Maintenance Hemodialysis
por: Labriola, Laura, et al.
Publicado: (2021)

Granulomatous vasculitis after the AstraZeneca anti–SARS-CoV-2 vaccine
por: Gillion, Valentine, et al.
Publicado: (2021)

Secondary syphilis after renal transplantation
por: Ballout, Assma, et al.
Publicado: (2008)

SARS-CoV-2 causes a specific dysfunction of the kidney proximal tubule
por: Werion, Alexis, et al.
Publicado: (2020)

Cutaneous leishmaniasis due to Leishmania aethiopica: A therapeutic challenge
por: Mengeot, Laura, et al.
Publicado: (2021)

Evolution of Anti-SARS-CoV-2 Therapeutic Antibodies
por: Almagro, Juan C., et al.
Publicado: (2022)

Discolouration of plasma in therapeutic plasma exchange
por: Bala Kumar, SS Deepak, et al.
Publicado: (2021)

Humoral responses to BNT162b2 SARS-CoV-2 and hepatitis B vaccines are associated in patients on maintenance hemodialysis: a single-centre experience in Belgium
por: Van Regemorter, Elliott, et al.
Publicado: (2021)

Low rates of humoral response to BNT162b2 SARS-CoV-2 vaccination in patients with immune-mediated kidney diseases treated with rituximab
por: Demoulin, Nathalie, et al.
Publicado: (2021)

Patient outcome in antibody-positive systemic vasculitis treated with therapeutic plasma exchange
por: Tiwari, Aseem Kumar, et al.
Publicado: (2023)

Dynamics of anti-SARS-CoV-2 antibodies in repeat convalescent plasma donors
por: Franchini, Massimo, et al.
Publicado: (2021)

Effect of SARS-CoV-2 infection and pandemic period on healthcare-associated infections acquired in intensive care units
por: Lepape, Alain, et al.
Publicado: (2023)

Safe use of hydroxychloroquine and its combination with azithromycin in the context of Sars-CoV-2 outbreak: Clinical experience in a Belgian tertiary center
por: Pothen, Lucie, et al.
Publicado: (2020)

Therapeutic Plasma Exchange in Renal Disorders
por: Ranganathan, D., et al.
Publicado: (2019)

Therapeutic plasma exchange in hypertriglyceridemic patients
por: YILDIRIM ŞİMŞİR, Ilgın, et al.
Publicado: (2019)

Therapeutic plasma exchange in liver failure
por: Chris-Olaiya, Abimbola, et al.
Publicado: (2021)

Therapeutic Plasma Exchange: For Cancer Patients
por: Hu, Yuru, et al.
Publicado: (2022)

Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products
por: Romero, Carolina, et al.
Publicado: (2021)

The predictors of high titer of anti-SARS-CoV-2 antibody of convalescent plasma donors
por: Wardhani, Shinta Oktya, et al.
Publicado: (2021)

Assessing the Outcomes of Patients with Severe SARS-CoV-2 Infection after Therapeutic Plasma Exchange by Number of TPE Sessions
por: Porosnicu, Tamara Mirela, et al.
Publicado: (2023)

The Impact of Therapeutic Plasma Exchange on Inflammatory Markers and Acute Phase Reactants in Patients with Severe SARS-CoV-2 Infection
por: Porosnicu, Tamara Mirela, et al.
Publicado: (2023)

Use of therapeutic plasma exchange to treat nonsteroidal anti‐inflammatory drug overdose in dogs
por: Rosenthal, Melisa G., et al.
Publicado: (2019)

Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products—an update
por: Romero, Carolina, et al.
Publicado: (2022)

Correlation of ENT Symptoms with Age, Sex, and Anti-SARS-CoV-2 Antibody Titer in Plasma
por: Kwaśniewska, Aleksandra, et al.
Publicado: (2023)

Therapeutic plasma exchange in adult critically ill patients with life-threatening SARS-CoV-2 disease: A pilot study
por: Faqihi, Fahad, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_36cnb8qqgeadpgqaf17kcgujvo